Pediatric Glaucoma Clinical Trial
Official title:
Comparison of the Ahmed Glaucoma Valve FP7 and FP8 in Pediatric Glaucoma: a Randomized Clinical Trial.
The purpose of this study is to compare the success rates and complications of two models of Ahmed glaucoma implants (FP7 and FP8) in patients with pediatric glaucoma.
INTRODUCTION
The drainage implants have become an important alternative in the treatment of pediatric
glaucoma refractory to angular and filtration surgery or medical therapy (1). Such implants
drain the aqueous humor from the anterior chamber of the eye to a plate positioned above the
sclera, between the rectus muscles. The aqueous humor goes through the pseudocyst that forms
around the plate by passive diffusion and is drained by the venous capillaries and lymphatic
system.
The Ahmed drainage implant (New World Medical, Inc., Rancho Cucamonga, CA, USA) is a device
with flow restrictors, which decreases the incidence of postoperative complications such as
hypotony (2-3). It is made of silicone and comes in two sizes. The FP7 model has a surface
of 184 mm2, 13mm wide and 16mm long. The FP8 model presents 96mm2 surface, 9.6 mm wide and
10mm long.
Studies in animals and adult humans suggest that the surface area of the implant plate is
directly related to the amount of aqueous fluid drained through the same (4-7). In contrast,
a very large implant can result in the extrusion of the same, uncontrolled intraocular
pressure, corneal injury by endothelial touch, patient discomfort and ocular motility
problems. The use of pediatric size implants in small eyes can avoid such complications. A
high rate (34.8%) of anterior plate of the tubes in children under 2 years of age has been
reported (8-9). On the other hand, the use of pediatric implante may affect the control of
intraocular pressure (IOP) due to reduced drainage area (10), especially in eyes with
increasing axial diameter, a result of increased eye pressure that happens in children with
glaucoma. However, there is no study in the literature comparing different sizes of drainage
implants in pediatric patients.
A study to compare the success rates and complications between FP7 and FP8 models is
essential in order to standardize a conduct in choosing the type of implant. Currently, the
choice of the drainage implant model to be used in every child lies on the free choice and
personal preference of the surgeon. There is no standard procedure, based on scientific
evidence for this choice.
OBJECTIVES
Compare the success rates and complications of two models of Ahmed drainage implant (FP7 and
FP8) in patients with pediatric glaucoma.
MATERIALS AND METHODS
This clinical trial is a prospective, randomized, masked to the evaluator to be held at the
Department of Ophthalmology, Federal University of Sao Paulo.
Will be included children between 0 and 10 years of age with glaucoma and surgical
indication for glaucoma drainage implant. Surgical indication for implantation of Ahmed
drainage occurs in some situations: 1) children with primary congenital glaucoma that
undergone angular surgery (goniotomy and / or trabeculotomy) who did not respond
satisfactorily to surgery, 2) children with glaucoma secondary to aphakia who have the
primary indication for implantation of Ahmed drainage, 3) children with glaucoma secondary
to other eye disorders where medical treatment is not satisfactory.
A term of consent will be obtained from parents or legal guardians of the child, in which
all the risks inherent to the surgical procedure will be clarified. Such risks are proper to
antiglaucomatous surgery are:
1. Early: hypotony, hyphema, tube endothelial touch, choroidal detachment, leakage of
aqueous, vitreous hemorrhage, retinal detachment, loss of light perception
2. late: uncontrolled intraocular pressure, persistent hypotony, scleral patch resorption,
extrusion of the tube, retinal detachment, loss of light perception (11-18).
Considering that the selected patient has already the surgical indication for Ahmed drainage
implant, the inclusion of this child in the study does not bring additional risks or
discomforts to the same.
The model of the drainage implant will be chosen through allocation from a
computer-generated random table.
Children enrolled in the study will be divided into two groups (one group will receive the
model FP7 and another group will receive the model FP8) with the number of 20 participants
in each group, totaling 40 children.
The surgeries will be performed by experienced surgeons from Glaucoma Sector from Department
of Ophthalmology, Federal University of Sao Paulo.
The plate of the Ahmed drainage implant will be placed in one of the quadrants selected from
the extraocular muscles between 8 and 10 mm away from the corneal limbus. The tube will have
its distal portion inserted 2-3mm into the anterior chamber of the eye in the iris plane.
The exposed portion of the tube is covered with donor sclera.
The children included in the study will be examined before surgery, which will be measured
your visual acuity, biomicroscopy, IOP, Retinography and axial length of the eye.
Immediately after surgery, with a compass we will measure the distance between the plate of
drainage implant and corneal limbus.
Children will be examined again after 6 months and 1 year of surgery. We will perform the
measurement of visual acuity, biomicroscopy, IOP, Retinography, axial length and measurement
of the distance from the plate of the implant and corneal limbus. Post-operative
examinations will be performed under narcosis, in hospitals (when it is impossible to take
measures in an outpatient setting due to lack of cooperation of the child), by a doctor from
congenital glaucoma sector who were not involved in the surgical procedure. The examination
under narcosis involves risk to the child, which include cough, nausea, vomiting,
laryngospasm, bronchospasm, apnea, bradycardia, tachycardia, hypertension, anxiety (19-21).
Two types of outcome will be considered in this study. The primary endpoint is to evaluate
the position of the drainage implant plate and if the plate is positioned at a distance ≥ 8
mm from the corneal limbus after 1 year of surgery, considered successful. If the dish drain
implant is positioned at a distance <8 mm from the corneal limbus, we have a failure.
As a secondary outcome, we evaluate the variation in IOP preoperative and postoperative. We
will use as a criterion of success an IOP ≤ 21 mm Hg and> 5 mmHg and a 30% reduction of
preoperative IOP. If the patient meets these criteria, without the use of eyedrop,
classified as complete success. If the use of eyedrop is necessary to meet the criteria, a
qualified success will be defined.
For failure criterion is assumed: IOP ≤ 5 mmHg or > 21 mm Hg, even with the use of eye
drops, need for further surgery, and / or loss of light perception.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01652664 -
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
|
Phase 3 | |
| Enrolling by invitation |
NCT05401760 -
Combined Phacoaspiration and Angle Surgery Versus Phacoaspiration in Pediatric Cataract
|
N/A | |
| Recruiting |
NCT03972852 -
Establishment of an Anaesthetic Protocol for Examinations for Children With Glaucoma or Suspected Glaucoma
|